Antiprothrombin Antibody Characterization
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Variable analysis
- Rivaroxaban (Xarelto) from Bayer Schering Pharma AG
- Anti-FcγRIIA monoclonal antibody (mAb) IV.3 purified in the laboratory from a hybridoma
- Antiprothrombin mAb 28F4 (a mouse IgG antibody)
- Antiprothrombin fragment 1+2 mAbs 3B1, 6A3, 11H2, and 8H11 developed and produced according to standard procedures
- LAC measured by activated partial thromboplastin time (Diagnostica Stago), dilute Russell Viper Venom Time (Diagnostica Stago), and Ecarin Clotting Time (ECT; Diagnostic Reagents)
- Purified human prothrombin from Synapse Research Institute (Maastricht, The Netherlands)
- Sheep anti-human prothrombin IgG horseradish peroxidase–labeled antibody from Affinity Biologicals, Inc.
- Prothrombin fragment 1+2 from Haematologic Technologies, Inc.
- All other reagents previously described or from Sigma-Aldrich
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!